BARTOLONI BOCCI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 8.668
AS - Asia 6.983
EU - Europa 6.791
SA - Sud America 1.418
AF - Africa 196
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.074
Nazione #
US - Stati Uniti d'America 8.475
SG - Singapore 3.338
IE - Irlanda 1.206
IT - Italia 1.195
BR - Brasile 1.108
RU - Federazione Russa 1.084
HK - Hong Kong 984
FR - Francia 823
CN - Cina 821
VN - Vietnam 761
UA - Ucraina 678
SE - Svezia 577
DE - Germania 369
FI - Finlandia 283
KR - Corea 230
IN - India 195
GB - Regno Unito 168
AR - Argentina 108
CA - Canada 94
BD - Bangladesh 91
IQ - Iraq 73
TR - Turchia 68
ZA - Sudafrica 60
AT - Austria 56
MX - Messico 55
NL - Olanda 53
PL - Polonia 52
CH - Svizzera 51
UZ - Uzbekistan 50
PK - Pakistan 49
CO - Colombia 48
EC - Ecuador 47
JP - Giappone 44
ID - Indonesia 42
VE - Venezuela 38
ES - Italia 36
SA - Arabia Saudita 35
MA - Marocco 32
CZ - Repubblica Ceca 31
PH - Filippine 28
KE - Kenya 26
MY - Malesia 24
LB - Libano 23
BE - Belgio 21
CL - Cile 18
UY - Uruguay 18
EG - Egitto 16
LT - Lituania 15
TN - Tunisia 15
IL - Israele 14
PY - Paraguay 14
AE - Emirati Arabi Uniti 13
OM - Oman 13
RO - Romania 13
AL - Albania 12
GR - Grecia 11
JO - Giordania 11
DZ - Algeria 10
HU - Ungheria 10
PE - Perù 10
AU - Australia 9
ET - Etiopia 9
KZ - Kazakistan 9
NP - Nepal 9
PS - Palestinian Territory 9
CR - Costa Rica 8
PT - Portogallo 8
PA - Panama 7
TH - Thailandia 7
AZ - Azerbaigian 6
BG - Bulgaria 6
BO - Bolivia 6
KG - Kirghizistan 6
NI - Nicaragua 6
EU - Europa 5
JM - Giamaica 5
MD - Moldavia 5
RS - Serbia 5
AO - Angola 4
CY - Cipro 4
DO - Repubblica Dominicana 4
KW - Kuwait 4
LV - Lettonia 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
GT - Guatemala 3
LY - Libia 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
ZW - Zimbabwe 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
DK - Danimarca 2
GY - Guiana 2
HN - Honduras 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 24.033
Città #
Singapore 2.284
Dublin 1.199
Chandler 1.138
Hong Kong 978
San Jose 764
San Mateo 641
Ashburn 578
Boardman 415
Dong Ket 390
Santa Clara 373
Moscow 370
Lauterbourg 298
Perugia 289
Medford 283
Princeton 282
Altamura 267
Jacksonville 241
Seoul 229
Lawrence 228
Wilmington 212
Des Moines 183
Beijing 167
Andover 155
Los Angeles 150
Ho Chi Minh City 118
Munich 118
The Dalles 115
Ann Arbor 109
New York 100
São Paulo 100
Hanoi 95
Helsinki 86
Saint Petersburg 85
Piscataway 78
Norwalk 65
San Paolo di Civitate 64
Rio de Janeiro 39
Tokyo 38
Falls Church 37
Milan 37
Rome 35
Frankfurt am Main 34
Johannesburg 34
Montreal 34
Nuremberg 34
Tashkent 34
Atlanta 33
Cambridge 32
Council Bluffs 31
Dallas 31
Warsaw 31
Vienna 30
Woodbridge 30
Brooklyn 29
Chicago 29
Baghdad 28
Chennai 28
Houston 28
Shanghai 27
Stockholm 27
Orem 26
Manchester 25
San Francisco 25
Belo Horizonte 24
Nairobi 24
Mumbai 23
Turku 22
Boston 21
Denver 21
Hefei 21
Redmond 20
Amsterdam 19
Brussels 19
Ottawa 19
Porto Alegre 19
Redwood City 19
Ribeirão Preto 19
Columbus 18
Da Nang 17
Guayaquil 17
London 17
Izmir 16
Mexico City 16
Den Haag 15
Montevideo 15
Poplar 15
Seattle 15
Toronto 15
Buenos Aires 14
Caracas 14
Curitiba 14
Haiphong 14
Medellín 14
Phoenix 14
Salvador 14
Biên Hòa 13
Bologna 13
Istanbul 13
Quito 13
Santo André 13
Totale 14.722
Nome #
Osteoporosi regionale migrante: un caso clinico con dettagliata documentazione RMN. 289
Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment 209
Identificazione della lipocaina come nuovo autoantigene nella sindrome di Sjögren primaria. 149
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. 133
Sindrome algodistrofica paraneoplastica: case report e possibile approccio terapeutico. 131
Classical and autoimmune factors associated with intima-media thickness in rheumatoid arthritis 124
Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren's syndrome: a novel pathogenetic scenario? 121
Associazione tra anticorpi anti-citrullina ed aterosclerosi subclinica in una coorte di soggetti affetti da artrite reumatoide. 120
Accelerated atherosclerosis in systemic lupus erythematosus and other connective tissue diseases. 118
Analisi della correlazione tra distensione della capsula articolare ed ipercarico metatarsale in soggetti con metatarsalgia meccanica. 118
Identification of regulatory T cells in systemic lupus erythematosus 117
A microbial polysaccharide promotes selective elimination of pathogenic T cells from peripheral blood of rheumatoid arthritis patients by apoptosis induction. 117
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study. 116
AB0037 CD4+CD25-GITR+regulatory T cells are expanded in the blood, display suppressive function and are inversely correlated with disease activity in patients with primary Sjögren’s syndrome 114
Ambiente e malattie reumatiche: il fumo. 112
Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in rheumatoid arthritis patients 112
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study. 111
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. 110
Expansion of regulatory GITR+CD25low/-CD4+ T cells in systemic lupus erythematosus patients 110
CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. 110
Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New 109
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 109
A Platelet's Guide to Synovitis 109
Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation--a homogeneous, multiplexed system. 108
Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibody. 108
Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage? 107
A8. 6 A novel therapeutic approach in systemic rheumatic autoimmune disorders: encapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells 107
Immunomodulatory effects of human umbelical cord Wharton jelly-derived mesenchymal stem cells (hUCMS) on circulating T-cell subsets in patients with Sjogren's syndrome 105
Isolation and characterization of a new human T regulatory cell subset from peripheral blood CD4+ T lymphocyte 104
A Higher Disease Activity in Anti-Ssa/ssb Positive Sjögren's Syndrome Is Explained by A Higher Clinical and Biological B-Cell Activation: Table 1 104
Microbiota and arthritis: cause or consequence? 100
Heat shock protein-60 and -65, and anti-oxidized LDL autoantibodies in Sjogren's syndrome 100
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 100
Autoimmune hypophysitis 100
Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). 99
Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations. 98
Policondrite ricorrente e sindrome mieloproliferativa cronica in soggetto con spondilite anchilosante: effetto del trattamento con anti-TNF alpha. 98
The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren's syndrome 98
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives 98
La sclerosi sitemica progressiva 97
Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis. 97
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 97
Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications. 97
Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30. 96
Role of regulatory T cells in rheumatoid arthritis: fact and hypothesis 96
DETERMINATION OF TRPV1+/T LYMPHOCYTES IN INFLAMMATORY ARTHRITIS AND THEIR CORRELATION WITH ULTRASOUND FINDINGS 96
Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: A pilot study 96
Circulating interferon-inducible protein IFI16 correlates with clinical and serological features in rheumatoid arthritis. 96
Anticyclic Citrullinated Peptide Antibodies in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: Clinical or Pathogenic Significance? 95
Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity 95
Association Between Glandular Infiltrate and Leukopenia in Sjögren Syndrome (SS): Data From the Italian Research Group on SS (GRISS) 95
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature 95
Rituximab treatment for persistent scleritis associated with rheumatoid arthritis 94
Characterization of a new regulatory CD4+ T cell subset in primary Sjogren's syndrome. 94
Association between clinical, histopathological and molecular features in primary Sjögren’s Syndrome: a retrospective study 94
The circulating interferon-inducible protein IFI16 correlates with clinical and serological features in Rheumatoid Arthritis 94
A9.18 Potential Therapeutic Application of Human Umbilical Cord wharton Jelly Derived Mesenchymal Stem Cells in Primary Sjogren's Syndrome 94
L'ipertensione arteriosa polmonare nelle malattie reumatiche 93
Quantificazione del DNA circolante nelle malattie reumatiche autoimmuni: ipotesi su una possibile correlazione con l’attività di malattia 93
Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies. 93
Acro-osteolysis of the big toe in a patient with psoriatic arthritis. 93
Rituximab in primary Sjögren's syndrome: a ten-year journey. 93
Serum interleukin-17 in primary Sjögren's syndrome: association with disease duration and parotid gland swelling. 93
The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients. 93
Characterisation of articular manifestations in primary Sjögren's syndrome: clinical and imaging features 93
Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future 93
Associazione tra sindrome di Sjögren primaria e malattia celiaca. 92
Recent views on the pathogenesis of cardiovascular damage associated with rheumatoid arthritis 91
Gli Esami di autoimmunologia nella diagnosi e nel monitoraggio della sclerosi sistemica-il quesito del clinico - 21° Congresso Nazionale SIMEL 90
Association of subclinical atherosclerosis and leukopenia in systemic autoimmune diseases 90
La sindrome di Sjogren 90
GALACTOXYLOMANNAN IS A POWERFUL IMMUNE SYSTEM MODULATOR ABLE TO REBALANCE TREG/TH17 RATIO IN RHEUMATOID ARTHRITIS 90
AB0191 Clinical significance of multiple autoantibody specificities in rheumatoid arthritis: the role of anti-citrullinated alpha enolase and anti-interferon inducible protein 16 90
IL-17 producing-DN T cells are expanded in the blood, infiltrate salivary glands and are resistant to corticosteroids in sjÖgren’s syndrome 90
Circulating Endothelial Microparticles and Endothelial Progenitors Cells in Primary SjÖGren's Syndrome: New Markers of Chronic Endothelial Damage? 90
Unfolding dermatologic spectrum of Behçet's disease in Italy: real-life data from the International AIDA Network Behçet's disease Registry 89
Crescentic glomerulonephritis and circulating antineutrophil cytoplasmic antibodies in scleroderma: a case report and review of the literature 89
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 89
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 89
Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment 89
Low level of heat shock proteins-60 and-65 autoantibodies in Sjogren's syndrome 88
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide. 88
Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link 87
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy 87
Functional Improvement of Regulatory T Cells From Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan 86
A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T lymphocyte arm and potentiates the regulatory counterpart in rheumatoid arthritis 86
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies 86
A Training Tool to support the management and diagnosis of Sjögren's syndrome 86
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis 85
“Artrite reumatoide ed altri reumatismi infiammatori cronici: inquadramento attuale” 85
CD4+CD28- lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients 85
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 85
Sjogren's Syndrome: Novel Insights in Pathogenic, Clinical and Therapeutic Aspects 85
Endothelial Microparticles and Circulating Endothelial Progenitor Cells in Primary SjöGren’s Syndrome Patients: Correlation with Clinical and Immunological Features 85
Extra-articular rheumatoid arthritis 84
One year in review 2019: Sjögren's syndrome 84
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 84
Correspondence on a € Anti-inflammatory therapy for COVID-19 infection: The case for colchicine' 84
JAK inhibitors and autoimmune rheumatic diseases 83
Precocious intima-media thickening in patients with primary Sjögren's syndrome 83
Totale 10.121
Categoria #
all - tutte 111.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.270


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021589 0 0 0 0 0 0 0 0 0 69 98 422
2021/20222.266 33 451 62 109 101 37 43 690 31 60 269 380
2022/20234.081 308 736 36 304 312 523 8 185 1.493 11 126 39
2023/20241.464 112 174 69 43 22 76 294 38 122 45 226 243
2024/20254.408 75 419 79 158 562 179 95 298 1.083 275 824 361
2025/20268.512 744 539 517 1.112 1.099 722 1.612 582 950 635 0 0
Totale 24.828